Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Thousands of demonstrators protest against the current measures to curb the spread of the coronavirus, in Berlin, Aug. 1. Photo: John MacDougall/AFP via Getty Images

Berlin police said Saturday night at least 18 officers were injured while trying to disperse a large crowd protesting Germany's coronavirus lockdown measures, according to a DW.com translation.

The big picture: Many in the estimated crowd of 17,000, made up of conspiracy theorists, right-wing populists and others, were not wearing masks, reports AP, which notes: "Unlike the U.S., Brazil and Britain, Germany’s government has been praised worldwide for its management of the pandemic." The country has confirmed more than 211,000 cases and just over 9,100 deaths from COVID-19, per Johns Hopkins data.

A tweet previously embedded here has been deleted or was tweeted from an account that has been suspended or deleted.

Editor's note: The top photo in this post has been replaced. The earlier photo depicted a demonstration against evictions.

Go deeper

Updated Nov 10, 2020 - World

In photos: Coronavirus restrictions grow across Europe

A waiter stands on an empty street in downtown Lisbon on Nov. 9, after Portugal introduced a night-time curfew for 70% of the population, including the capital and also the coastal city of Porto. It'll last for at least two weeks, per the BBC. Photo: Patricia De Melo Moreira/AFP via Getty Images

Portugal and Hungary have become the latest European countries to impose partial lockdowns, with curfews going into effect overnight. Governments across the continent are imposing more restrictions in attempts to curb COVID-19 spikes.

The big picture: Over 9.2 million cases have been reported to the European Centre for Disease Control. Per the ECDC, France has the most (almost 1.8 million) followed by Spain (over 1.3 million) and the United Kingdom (nearly 1.2 million). The COVID death rate per 100,000 of the population is highest in the Czech Republic (25), followed by Belgium (19) and Hungary (10.4).

Updated Oct 16, 2021 - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Booster shots overtake first doses in the U.S. — Pfizer to vaccinate entire Brazilian city as part of study — FDA panel endorses shot of J&J booster for adultsU.S. to lift restrictions for fully vaccinated international travelers on Nov. 8.
  2. Health: New cases down, but the West is at risk — Low vaccination rates exacerbate America's caregiving crisis — COVID is here to stay. So what does "victory" look like? — FDA will review Merck COVID-19 pill.
  3. Politics: NHL announces all but four players have been vaccinated — WHO names new advisory group on COVID origins — Biden admin warns Moderna to "step up" global vaccine supply.
  4. Education: LA extends deadline for school employee vaccinations amid staffing shortage — Parent sues Wisconsin school district after child tests positive — Arizona can't use aid for anti-mask education grants, Treasury says.
  5. Variant tracker: Where different strains are spreading.
Nov 10, 2020 - Health

FDA grants emergency use authorization for Eli Lilly COVID-19 treatment

Photo: Scott Eisen/Getty Images

The FDA announced on Monday it has issued an emergency use authorization for Eli Lilly's antibody therapy, bamlanivimab, to treat mild to moderate cases of COVID-19.

Why it matters: The treatment is authorized for people "who are at high risk for progressing to severe COVID-19 and/or hospitalization," including people who are 65 and older, and/or people with certain chronic illnesses.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!